Following comments received in the draft scope consultation NICE decided to split this Multiple Technology Appraisal (MTA) of three drugs into three separate Single Technology Appraisals (STAs). The STAs are:
[ID1478] – dapagliflozin
[ID1376] – sotagliflozin
[ID1275] – empagliflozin
This MTA is therefore suspended.